Cargando…
Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda
Based on its predicted ability to affect transmissibility and pathogenesis, surveillance studies have highlighted the role of a specific mutation (P681R) in the S1/S2 furin cleavage site of the SARS-CoV-2 spike protein. Here we analyzed A.23.1, first identified in Uganda, as a P681R-containing virus...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259907/ https://www.ncbi.nlm.nih.gov/pubmed/34230931 http://dx.doi.org/10.1101/2021.06.30.450632 |
_version_ | 1783718731189321728 |
---|---|
author | Lubinski, Bailey Frazier, Laura E. Phan, My V.T. Bugembe, Daniel L. Cunningham, Jessie L. Tang, Tiffany Daniel, Susan Cotten, Matthew Jaimes, Javier A. Whittaker, Gary R. |
author_facet | Lubinski, Bailey Frazier, Laura E. Phan, My V.T. Bugembe, Daniel L. Cunningham, Jessie L. Tang, Tiffany Daniel, Susan Cotten, Matthew Jaimes, Javier A. Whittaker, Gary R. |
author_sort | Lubinski, Bailey |
collection | PubMed |
description | Based on its predicted ability to affect transmissibility and pathogenesis, surveillance studies have highlighted the role of a specific mutation (P681R) in the S1/S2 furin cleavage site of the SARS-CoV-2 spike protein. Here we analyzed A.23.1, first identified in Uganda, as a P681R-containing virus several months prior to the emergence of B.1.617.2 (Delta variant). We performed assays using peptides mimicking the S1/S2 from A.23.1 and B.1.617 and observed significantly increased cleavability with furin compared to both an original B lineage (Wuhan-Hu1) and B.1.1.7 (Alpha variant). We also performed cell-cell fusion and functional infectivity assays using pseudotyped particles and observed an increase in activity for A.23.1 compared to an original B lineage spike. However, these changes in activity were not reproduced in the B lineage spike bearing only the P681R substitution. Our findings suggest that while A.23.1 has increased furin-mediated cleavage linked to the P681R substitution, this substitution needs to occur on the background of other spike protein changes to enable its functional consequences. |
format | Online Article Text |
id | pubmed-8259907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-82599072021-07-07 Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda Lubinski, Bailey Frazier, Laura E. Phan, My V.T. Bugembe, Daniel L. Cunningham, Jessie L. Tang, Tiffany Daniel, Susan Cotten, Matthew Jaimes, Javier A. Whittaker, Gary R. bioRxiv Article Based on its predicted ability to affect transmissibility and pathogenesis, surveillance studies have highlighted the role of a specific mutation (P681R) in the S1/S2 furin cleavage site of the SARS-CoV-2 spike protein. Here we analyzed A.23.1, first identified in Uganda, as a P681R-containing virus several months prior to the emergence of B.1.617.2 (Delta variant). We performed assays using peptides mimicking the S1/S2 from A.23.1 and B.1.617 and observed significantly increased cleavability with furin compared to both an original B lineage (Wuhan-Hu1) and B.1.1.7 (Alpha variant). We also performed cell-cell fusion and functional infectivity assays using pseudotyped particles and observed an increase in activity for A.23.1 compared to an original B lineage spike. However, these changes in activity were not reproduced in the B lineage spike bearing only the P681R substitution. Our findings suggest that while A.23.1 has increased furin-mediated cleavage linked to the P681R substitution, this substitution needs to occur on the background of other spike protein changes to enable its functional consequences. Cold Spring Harbor Laboratory 2022-03-28 /pmc/articles/PMC8259907/ /pubmed/34230931 http://dx.doi.org/10.1101/2021.06.30.450632 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Lubinski, Bailey Frazier, Laura E. Phan, My V.T. Bugembe, Daniel L. Cunningham, Jessie L. Tang, Tiffany Daniel, Susan Cotten, Matthew Jaimes, Javier A. Whittaker, Gary R. Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda |
title | Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda |
title_full | Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda |
title_fullStr | Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda |
title_full_unstemmed | Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda |
title_short | Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda |
title_sort | spike protein cleavage-activation in the context of the sars-cov-2 p681r mutation: an analysis from its first appearance in lineage a.23.1 identified in uganda |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259907/ https://www.ncbi.nlm.nih.gov/pubmed/34230931 http://dx.doi.org/10.1101/2021.06.30.450632 |
work_keys_str_mv | AT lubinskibailey spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT frazierlaurae spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT phanmyvt spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT bugembedaniell spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT cunninghamjessiel spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT tangtiffany spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT danielsusan spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT cottenmatthew spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT jaimesjaviera spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda AT whittakergaryr spikeproteincleavageactivationinthecontextofthesarscov2p681rmutationananalysisfromitsfirstappearanceinlineagea231identifiedinuganda |